![Thierry Thaure](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Thierry Thaure
Gründer bei
GT Metabolic Solutions, Inc.
Profil
Thierry Bernard Thaure was the founder of Cephea Valve Technologies, Inc., founded in 2012, where the title held was Chief Executive Officer from 2012 to 2019.
Mr. Thaure is the founder of GT Metabolic Solutions, Inc., founded in 2020, holding the title Chief Executive Officer & Director since 2021.
Mr. Thaure is currently Director at CellTivity Scientific, Inc. since 2019.
Former positions include President & Chief Executive Officer at EndoGastric Solutions, Inc. from 2010 to 2011; Chief Executive Officer & Director at Mauna Kea Technologies, Inc. from 2001 to 2012; President, Chief Executive Officer & Director at TriFlo Cardiovascular, Inc. from 2019 to 2021; Independent Director at Pulse Biosciences, Inc. from 2015 to 2017; Director at FlexDex, Inc. from 2019 to 2020; Director-International Business at Origin Medsystems, Inc. from 1995 to 1997; Director at MedTech Acquisition Corp.
from 2021 to 2022; Principal at Guidant Corp.; Vice President-Sales & Marketing at Intuitive Surgical, Inc. from 1997 to 2001; Senior Vice President-Sales & Marketing, GM at Accuray, Inc. from 2001 to 2004.
Education includes undergraduate studies at Duke University and an MBA from Kellogg School of Management.
Aktive Positionen von Thierry Thaure
| Unternehmen | Position | Beginn |
|---|---|---|
Aquyre Biosciences, Inc.
 Aquyre Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company that develops cell-based therapies and regenerative medicine solutions | Direktor/Vorstandsmitglied | 01.01.2019 |
GT Metabolic Solutions, Inc.
 GT Metabolic Solutions, Inc. Medical SpecialtiesHealth Technology Develops bypass technology for bariatric, metabolic, and digestive surgery | Gründer | 01.05.2020 |
Ehemalige bekannte Positionen von Thierry Thaure
| Unternehmen | Position | Ende |
|---|---|---|
TriFlo Cardiovascular, Inc.
 TriFlo Cardiovascular, Inc. Medical/Nursing ServicesHealth Services Provides healthcare services | Vorstandsvorsitzender | 01.10.2021 |
FlexDex, Inc.
 FlexDex, Inc. Medical SpecialtiesHealth Technology Manufactures surgical device | Direktor/Vorstandsmitglied | 01.01.2020 |
Cephea Valve Technologies, Inc.
 Cephea Valve Technologies, Inc. Medical/Nursing ServicesHealth Services Provides catheter delivered mitral valve regurgitation products, heart valves for the treatment of coronary artery disease in patients and offers catheter based therapies such as balloons and stents for aortic valves replacements | Vorstandsvorsitzender | 01.01.2019 |
| PULSE BIOSCIENCES, INC. | Direktor/Vorstandsmitglied | 02.11.2017 |
Mauna Kea Technologies, Inc.
 Mauna Kea Technologies, Inc. Medical SpecialtiesHealth Technology Develops and sells optical biopsy devices for real-time cellular imaging | Vorstandsvorsitzender | 01.06.2012 |
Ausbildung von Thierry Thaure
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
48
Beziehungen ersten Grades
15
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 15 |
|---|---|
Guidant Corp.
 Guidant Corp. Medical SpecialtiesHealth Technology Develops cardiovascular medical products | Health Technology |
Intuitive Surgical, Inc.
 Intuitive Surgical, Inc. Medical SpecialtiesHealth Technology Designs, manufactures and markets robotic surgical systems | Health Technology |
EndoGastric Solutions, Inc.
 EndoGastric Solutions, Inc. Medical SpecialtiesHealth Technology Manufactures and markets proprietary disposable medical devices | Health Technology |
Cephea Valve Technologies, Inc.
Cephea Valve Technologies, Inc. Medical/Nursing ServicesHealth Services Provides catheter delivered mitral valve regurgitation products, heart valves for the treatment of coronary artery disease in patients and offers catheter based therapies such as balloons and stents for aortic valves replacements | Health Services |
Pulse Biosciences, Inc.
 Pulse Biosciences, Inc. Medical SpecialtiesHealth Technology Operates as a bioelectric medicine company which develops medical devices | Health Technology |
FlexDex, Inc.
FlexDex, Inc. Medical SpecialtiesHealth Technology Manufactures surgical device | Health Technology |
Duke University
 Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Origin Medsystems, Inc.
 Origin Medsystems, Inc. Medical SpecialtiesHealth Technology Manufactures medical devices | Health Technology |
Accuray, Inc.
 Accuray, Inc. Medical SpecialtiesHealth Technology Manufactures medical equipment | Health Technology |
Kellogg School of Management
 Kellogg School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Mauna Kea Technologies, Inc.
Mauna Kea Technologies, Inc. Medical SpecialtiesHealth Technology Develops and sells optical biopsy devices for real-time cellular imaging | Health Technology |
TriFlo Cardiovascular, Inc.
TriFlo Cardiovascular, Inc. Medical/Nursing ServicesHealth Services Provides healthcare services | Health Services |
MedTech Acquisition Corp.
 MedTech Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Aquyre Biosciences, Inc.
Aquyre Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company that develops cell-based therapies and regenerative medicine solutions | Commercial Services |
GT Metabolic Solutions, Inc.
GT Metabolic Solutions, Inc. Medical SpecialtiesHealth Technology Develops bypass technology for bariatric, metabolic, and digestive surgery | Health Technology |
